AlzeCure releases company update following key Eli Lilly, QuantumCell partnerships
AlzeCure Pharma AB has published an updated English company presentation. The presentation, produced by FinWire, provides an updated view from CEO Martin Jönsson following collaboration and outlicensing agreements with US-based Eli Lilly and Denmark-based QuantumCell ApS relating to AlzeCure’s
<p>AlzeCure Pharma AB has published an updated English company presentation. The presentation, produced by FinWire, provides an updated view from CEO Martin Jönsson following collaboration and outlicensing agreements with US-based Eli Lilly and Denmark-based QuantumCell ApS relating to AlzeCure’s</p>